An analysis of adverse events reported for cannabis-derived and synthetic cannabis-related drug products using the FDA Adverse Event Reporting System (FAERS)

Brianna Costales
University of Florida

Background: There are no studies that have comprehensively reviewed safety profiles, including reported adverse drug events (ADEs), for cannabis-derived and synthetic products approved in the United States (U.S.) and internationally.